Company Analysis
Sign in

NeoGenomics, Inc. (NEO)

Nasdaq: NEO · Services-Testing Laboratories · Fort Myers, FL · filing with the SEC since 1999
Full chart Alerts Compare
Grade4.4
◀ Past 4.4● Present 3.9▶ Future 4.9
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$727M+10.1%
Net income-$108M-37.2%
Earnings per sharen/a
Operating cash flow$5.2M-25.5%
Cash$160M-56.5%
Debt$342M-36.8%
Shareholders’ equity$837M-7.3%
Shares, diluted128.1M+1.1%
Return on equity-12.9%
The recordfrom its filings
Filings in 202673
Newest filingOct 28 · 10-Q
Annual reportFeb 17, 2026
Quarterly reportOct 28, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$1.0M
Insider buys, 12 months$0.00
Patents granted24
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $788MNet income -$32.3MCash from operations $4.3Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Oct 28, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Oct 28, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Oct 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 5, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Sep 3, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 25, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 11, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton NEO · research, not advice